Target type: biologicalprocess
The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication by using a specialized DNA polymerase or replication complex to insert a defined nucleotide across the lesion. This process does not remove the replication-blocking lesions but does not causes an increase in the endogenous mutation level. For S. cerevisiae, RAD30 encodes DNA polymerase eta, which incorporates two adenines. When incorporated across a thymine-thymine dimer, it does not increase the endogenous mutation level. [GOC:elh]
Error-free translesion synthesis (TLS) is a crucial DNA repair mechanism that allows cells to bypass damaged DNA bases while maintaining the integrity of the genetic code. This process involves specialized DNA polymerases that can replicate past lesions that would normally stall the replicative polymerases.
Here's a detailed breakdown of the biological process:
1. **DNA Damage Recognition:** When DNA polymerase encounters a damaged base (e.g., a thymine dimer caused by UV radiation), it stalls, unable to proceed. This triggers the recruitment of specialized translesion synthesis (TLS) polymerases to the site of damage.
2. **TLS Polymerase Recruitment:** TLS polymerases are distinct from the replicative polymerases (Pol α, δ, and ε) and have unique structural features that allow them to accommodate damaged DNA. Proteins like PCNA (proliferating cell nuclear antigen) act as a sliding clamp, facilitating the switch from replicative to TLS polymerases.
3. **Bypass Synthesis:** Once bound to the damaged DNA, TLS polymerases utilize a different active site geometry and base pairing rules to synthesize DNA past the lesion. Some TLS polymerases can insert the correct base opposite the damaged base, while others may insert a non-canonical base that can be later replaced by a correct base.
4. **Switch Back to Replicative Polymerase:** After the TLS polymerase has bypassed the lesion, the replicative polymerase can resume DNA synthesis. This switching mechanism ensures that the majority of the genome is replicated by the high-fidelity replicative polymerases, minimizing the risk of mutations.
5. **Error-Free Repair:** Error-free translesion synthesis relies on the insertion of the correct base opposite the lesion. This accuracy is achieved by various mechanisms, including:
- **Specialized Active Sites:** TLS polymerases have evolved active sites that can accommodate damaged bases, allowing for accurate base pairing.
- **Base Excision Repair (BER):** After TLS, the damaged base can be removed by BER, allowing the correct base to be inserted.
- **Mismatch Repair (MMR):** MMR can also correct mismatches introduced during TLS, ensuring that the DNA sequence is restored to its original state.
6. **Importance of Error-Free TLS:** While TLS is essential for surviving DNA damage, it is a relatively error-prone process. Error-free TLS minimizes the risk of mutations and genomic instability, protecting cells from cancer and other genetic diseases.
7. **Regulation of TLS:** The activity of TLS polymerases is tightly regulated to minimize the risk of mutations. Several cellular factors, including the availability of TLS polymerases, the type of DNA damage, and the cellular stress response, influence TLS activity.
Error-free translesion synthesis is a complex and tightly regulated process that is essential for maintaining genome integrity. By allowing cells to bypass damaged DNA bases while minimizing the introduction of mutations, TLS plays a critical role in protecting cells from the deleterious effects of DNA damage.'
"
Protein | Definition | Taxonomy |
---|---|---|
DNA polymerase eta | A DNA polymerase eta that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y253] | Homo sapiens (human) |
DNA polymerase eta | A DNA polymerase eta that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y253] | Homo sapiens (human) |
DNA polymerase delta catalytic subunit | A DNA polymerase delta catalytic subunit that is encoded in the genome of human. [PRO:DNx, UniProtKB:P28340] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
aurintricarboxylic acid | aurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'. Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues. | monohydroxybenzoic acid; quinomethanes; tricarboxylic acid | fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist |
candesartan cilexetil | candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects | biphenyls | |
foscarnet | Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity. | carboxylic acid; one-carbon compound; phosphonic acids | antiviral drug; geroprotector; HIV-1 reverse transcriptase inhibitor; sodium-dependent Pi-transporter inhibitor |
ochracin | ochracin: produced by Aspergillus alutaceus; structure in first source | isochromanes | |
zidovudine triphosphate | |||
aphidicolin | aphidicolin : A tetracyclic diterpenoid that has an tetradecahydro-8,11a-methanocyclohepta[a]naphthalene skeleton with two hydroxymethyl substituents at positions 4 and 9, two methyl substituents at positions 4 and 11b and two hydroxy substituents at positions 3 and 9. An antibiotic with antiviral and antimitotical properties. Aphidicolin is a reversible inhibitor of eukaryotic nuclear DNA replication. Aphidicolin: An antiviral antibiotic produced by Cephalosporium aphidicola and other fungi. It inhibits the growth of eukaryotic cells and certain animal viruses by selectively inhibiting the cellular replication of DNA polymerase II or the viral-induced DNA polymerases. The drug may be useful for controlling excessive cell proliferation in patients with cancer, psoriasis or other dermatitis with little or no adverse effect upon non-multiplying cells. | tetracyclic diterpenoid | antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite |
pnu183792 | PNU183792: structure in first source | ||
ellagic acid | catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent | |
pecilocin | pecilocin: fungicidal antibiotic produced by Paecilomyces varioti Bainier var. antibioticus; structure | N-acylpyrrolidine | |
3-o-methylfunicone | 3-O-methylfunicone: derived from Penicillium pinophilum; structure in first source | ||
sch 725680 | Sch 725680: an aazaphilone from Aspergillus sp.; structure in first source | ||
pinophilin b | pinophilin B: from cultures of a fungus (Penicillium pinophilum Hedgcok) derived from a seaweed; structure in first source |